Literature DB >> 23925840

Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection.

Ijin Joo1, Jeong Min Lee.   

Abstract

Cholangiocarcinoma is the most common primary malignancy of the bile ducts which has several predisposing factors such as hepatolithiasis and primary sclerosing cholangitis, and can develop from precancerous conditions such as biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct. As surgical resection of early stage cholangiocarcinoma or precancerous lesions may provide better prognosis, early detection of those lesions is very important. Imaging studies play important roles in the diagnosis of bile duct tumors followed by appropriate management. Indeed, not only diagnosis of cholangiocarcinoma but also appropriate categorization of bile duct tumors based on their morphologic features and location on cross-sectional imaging studies, including computed tomography and magnetic resonance imaging, is important to predict their biologic behaviors, and choose relevant treatment strategies. We herein review the classification system of the bile duct tumors with their radiologic and pathologic findings as well as role of imaging in the early detection of bile duct tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925840     DOI: 10.1007/s00261-013-0027-3

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  14 in total

1.  Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway.

Authors:  Lei Kong; Qinghua Wu; Liangchao Zhao; Jinhua Ye; Nengping Li; Huali Yang
Journal:  Cell Cycle       Date:  2019-05-20       Impact factor: 4.534

Review 2.  [Precancerous and early stage cancer of the bile duct system].

Authors:  H-M Tautenhahn; S Brückner; F Rauchfuß; F Donndorf; M Ardelt; R Fahrner; A Tannapfel; U Settmacher
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

3.  In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils.

Authors:  Narong Khuntikeo; Attapol Titapun; Nittaya Chamadol; Wuttisak Boonphongsathien; Prakasit Sa-Ngiamwibool; Simon D Taylor-Robinson; Christopher A Wadsworth; Shuo Zhang; Evdokia M Kardoulaki; Richard R A Syms
Journal:  Hepat Med       Date:  2020-07-27

Review 4.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

Review 5.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

6.  Predictive and prognostic molecular markers for cholangiocarcinoma in Han Chinese population.

Authors:  Lingqin Meng; Zhong Tian; Yong Wang; Yuan Liu; Jingang Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 7.  Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.

Authors:  Ijin Joo; Haeryoung Kim; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

8.  Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells.

Authors:  Tae Won Kwak; Hye Lim Lee; Yeon Hui Song; Chan Kim; Jungsoo Kim; Sol-Ji Seo; Young-Il Jeong; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2017-10-17

Review 9.  Precursor Lesions of Cholangiocarcinoma: A Clinicopathologic Review.

Authors:  Bita Geramizadeh
Journal:  Clin Pathol       Date:  2020-06-15

10.  Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping.

Authors:  Narong Khuntikeo; Attapol Titapun; Nittaya Chamadol; Wuttisak Boonphongsathien; Prakasit Sa-Ngiamwibool; Simon D Taylor-Robinson; Christopher A Wadsworth; Shuo Zhang; Evdokia M Kardoulaki; Ian R Young; Richard R A Syms
Journal:  Hepat Med       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.